← Back
$SUPN All transactions

SUPERNUS PHARMACEUTICALS, INC.

▼ SELL 10b5-1 Plan

$ Value

$1.4M

Shares

29,513

Price

$47

Filed

Sep 24

Insider

Name

Khattar Jack A.

Title

President, CEO

CIK

0001539937

Roles

Director Officer

Transaction Details

Transaction Date

2025-09-23

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,140,883

Footnotes

Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2024. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.00 to $47.55. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. | The option vested in four equal installments beginning on March 1, 2017.

Filing Info

Accession No.

0001539937-25-000020

Form Type

4

Issuer CIK

0001356576

Khattar Jack A.'s History

Date Ticker Type Value
2025-10-09 SUPN M $2.1M
2025-10-09 SUPN $3.0M
2025-10-09 SUPN $79K
2025-10-09 SUPN M $0
2025-10-07 SCPH U
2025-10-07 SCPH D $0
2025-10-07 SCPH D $0
2025-10-07 SCPH D $0
2025-10-07 SCPH D $0
2025-10-02 SUPN M $57K

Other Insiders at SUPN (90d)

No other insider activity at this issuer in the last 90 days.